Skip to main content
. 2022 Dec 28;25(1):61–70. doi: 10.1111/jch.14606

TABLE 2.

The relationship between dietary electrolytes intake and the hypertensive disorders of pregnancy subtypes

PE SP PE+SP Gestational hypertension
Quintiles OR (95% CI) p‐value P for trend OR (95% CI) p‐value P for trend OR (95% CI) p‐value P for trend OR (95% CI) p‐value P for trend
Crude
Calcium intake in mg/day
<251 1.31 (1.00–1.70) .049 .02 1.08 (.67–1.73) .8 .6. 1.28 (1.02–1.62) .04 .01 1.25 (1.01–1.56) .04 .04
251–356 1.07 (.81–1.41) .6 1.11 (.68–1.81) .7 1.09 (.86–1.39) .5 1.10 (.88–1.37) .4
356–465 .85 (.64–1.14) .3 .89 (.53–1.48) .7 .90 (.70–1.15) .4 1.12 (.90–1.40) .3
465–623 .93 (.70–1.23) .6 .99 (.59–1.65) .96 .95 (.75–1.22) .7 1.04 (.83–1.30) .7
>623 Reference Reference Reference Reference
Potassium intake in mg/day
<1313 1.30 (.99–1.70) .06 .06 1.05 (.65–1.71) .8 .9 1.26 (1.00–1.60) .05 .048 1.12 (.90–1.38) .3 .2
1313–1704 1.11 (.84–1.47) .5 1.06 (.65–1.73) .8 1.15 (.90–1.46) .3 1.08 (.87–1.34) .5
1704–2104 1.01 (.76–1.35) .9 .82 (.49–1.38) .5 .99 (.77–1.27) .9 .95 (.76–1.19) .7
2104–2676 1.05 (.79–1.39) .7 1.11 (.66–1.86) .7 1.09 (.85–1.39) .5 .98 (.79–1.23) .9
>2676 Reference Reference Reference Reference
Sodium intake in mg/day
<1992 1.15 (.87–1.51) .3 .4 .96 (.59–1.56) .9 .96 1.11 (.88–1.41) .4 .4 1.02 (.83–1.26) .8 .8
1992–2621 1.03 (.78–1.36) .8 1.14 (.69–1.88) .6 1.09 (.86–1.39) .5 .92 (.74–1.14) .4
2621–3263 1.05 (.80–1.39) .7 1.19 (.72–1.99) .5 1.08 (.85–1.38) .5 .98 (.80–1.22) .9
3263–4170 1.03 (.78–1.36) .8 1.01 (.60–1.70) .98 1.05 (.82–1.35) .7 .90 (.73–1.12) .4
>4170 Reference Reference Reference Reference
Magnesium intake in mg/day
<142 1.28 (.98–1.68) .07 .1 1.12 (.69–1.80) .6 .9 1.25 (.99–1.58) .06 .1 1.11 (.90–1.38) .3 .2
142–179 1.06 (.80–1.40) .7 1.06 (.64–1.75) .8 1.09 (.86–1.39) .5 1.05 (.85–1.31) .6
179–217 .95 (.72–1.27) .7 .85 (.52–1.40) .5 .94 (.74–1.21) .6 .99 (.80–1.23) .9
217–272 1.00 (.75–1.32) .98 1.27 (.76–2.14) .4 1.07 (.84–1.36) .6 .95 (.76–1.19) .7
>272 Reference Reference Reference Reference
Na/K ratio
<1.23 .86 (.65–1.14) .3 .3 1.13 (.69–1.84) .6 .6 .91 (.72–1.16) .5 .5 .78 (.63–.97) .03 .01
1.23–1.45 1.12 (.86–1.47) .4 1.27 (.77–2.09) .3 1.14 (.90–1.44) .3 .90 (.72–1.11) .3
1.45–1.65 .89 (.67–1.17) .4 1.39 (.84–2.30) .2 1.00 (.78–1.27) .99 .94 (.77–1.17) .6
1.65–1.91 1.15 (.88–1.50) .3 1.15 (.70–1.88) .6 1.13 (.89–1.43) .3 1.05 (.86–1.30) .6
>1.91 Reference Reference Reference Reference
Energy in Kcal/day
<1,215 .94 (.72–1.23) .6 .9 1.00 (.64–1.56) .98 .98 .97 (.77–1.22) .8 .96 1.12 (.91–1.37) .3 .9
1215–1461 .97 (.74–1.26) .8 1.03 (.65–1.64) .9 1.01 (.80–1.27) .9 .84 (.67–1.05) .1
1,461–1,708 .82 (.62–1.08) .2 .76 (.45–1.27) .3 .82 (.64–1.05) .1 .86 (.69–1.07) .2
1708–2053 .87 (.66–1.14) .3 1.03 (.63–1.68) .9 .94 (.74–1.19) .6 1.05 (.85–1.30) .6
>2053 Reference Reference Reference Reference
Energy‐adjusted
Calcium intake in mg/day
<330 1.17 (.88 to 1.56) .3 .06 1.17 (.73 to 1.87) .5 .4 1.18 (.92–1.51) .2 .02 1.30 (1.04 to 1.62) .02 .01
330–420 1.48 (1.13–1.94) .01 1.32 (.82–2.13) .3 1.45 (1.15–1.84) .002 1.31 (1.05–1.63) .02
420–496 1.09 (.82–1.46) .6 1.12 (.68–1.85) .7 1.09 (.85–1.39) .5 1.11 (.89–1.39) .4
496–599 1.13 (.85–1.51) .4 1.13 (.68–1.88) .6 1.14 (.89–1.46) .3 1.13 (.90–1.41) .3
>599 Reference Reference Reference Reference
Potassium intake in mg/day
<1714 1.27 (.97–1.66) .08 .06 1.06 (.66–1.69) .8 .7 1.23 (.97–1.55) .09 .04 1.43 (1.14–1.79) 0 .002 .004
1714–1949 .99 (.74–1.31) .9 1.23 (.75–2.02) .4 1.07 (.84–1.36) .6 1.23 (.97–1.54) .08
1949–2150 1.17 (.89–1.54) .3 1.02 (.62–1.69) .9 1.15 (.90–1.46) .3 1.50 (1.20–1.88) <.001
2150–2423 .89 (.67–1.19) .4 1.04 (.63–1.73) .9 .94 (.73–1.20) .6 1.18 (.93–1.49) .2
>2423 Reference Reference Reference Reference
Sodium intake in mg/day
<2504 1.15 (.87–1.52) .3 .1 1.24 (.76–2.02) .4 .6 1.19 (.94–1.52) .2 .06 .94 (.75–1.17) .6 .1
2504–2946 1.26 (.96–1.65) .09 1.32 (.79–2.18) .3 1.30 (1.03–1.66) .03 .91 (.73–1.13) .4
2,946–3,332 1.01 (.76–1.34) .9 1.37 (.82–2.30) .2 1.09 (.85–1.40) .5 1.03 (.83–1.28) .8
3332–3835 1.02 (.76–1.35) .9 1.35 (.81–2.24) .2 1.11 (.86–1.42) .4 1.16 (.94–1.43) .2
>3835 Reference Reference Reference Reference
Magnesium in mg/day
<183 1.25 (.95–1.64) .1 .03 1.18 (.73–1.91) .5 .5 1.26 (.99–1.59) .06 .02 1.24 (1.00–1.55) .05 .04
183–203 1.20 (.91–1.59) .2 1.34 (.83–2.17) .2 1.26 (.99–1.60) .06 1.23 (.99–1.53) .07
203–220 1.09 (.82–1.44) .6 1.08 (.65–1.78) .8 1.09 (.86–1.40) .5 1.17 (.93–1.46) .2
220–243 .95 (.71–1.27) .7 1.26 (.76–2.10) .4 1.04 (.81–1.33) .8 1.12 (.90–1.41) .3
>243 Reference Reference Reference Reference
Na/K ratio
<1.23 .91 (.69–1.20) .5 .4 1.05 (.64–1.72) .8 .7 .93 (.73–1.19) .6 .6 .75 (.61–.94) .01 .005
1.23–1.45 1.11 (.85–1.46) .4 1.40 (.85 to 2.31) .2 1.16 (.92–1.47) .2 .82 (.66–1.02) .07
1.45–1.65 .86 (.64–1.14) .3 1.41 (.85 to 2.33) .2 .98 (.77–1.24) .8 .93 (.75–1.14) .5
1.65–1.91 1.18 (.91–1.54) .2 1.14 (.70 to 1.87) .6 1.16 (.91–1.46) .2 .95 (.78–1.17) .6
>1.91 Reference Reference Reference Reference

Notes: The independent variables (the electrolytes intake) were adjusted for maternal age, pre‐pregnancy body mass index, smoking status, alcohol consumption status, educational attainment, diabetes mellitus, systemic lupus erythematosus, family history of hypertensive disorders of pregnancy, family history of chronic hypertension, parity with or without hypertensive disorders of pregnancy, and conception by in vitro fertilization.

Pregnant women with chronic hypertension (CH) were included in the analysis with PE+SP as the outcome in the population, considered a risk factor for SP, and used as a covariate. Pregnant women with CH were excluded from the analysis with PE or gestational hypertension as the outcome, while pregnant women without CH were excluded from the analysis with SP as the outcome.

Abbreviations: CI: confidence interval; Na/K ratio, sodium‐to‐potassium intake ratio; OR, odds ratio; PE, pre‐eclampsia; PE+SP, pre‐eclampsia and superimposed pre‐eclampsia; SP, superimposed pre‐eclampsia.